BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Itani T, Jacobsen KH, Nguyen T, Wiktor SZ. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region. Vaccine 2014;32:6067-74. [PMID: 25236586 DOI: 10.1016/j.vaccine.2014.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Medić S, Anastassopoulou C, Milošević V, Dragnić N, Rajčević S, Ristić M, Petrović V. Declining seroprevalence of hepatitis A in Vojvodina, Serbia. PLoS One 2019;14:e0217176. [PMID: 31163046 DOI: 10.1371/journal.pone.0217176] [Reference Citation Analysis]
2 Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis 2019;19:651. [PMID: 31331281 DOI: 10.1186/s12879-019-4235-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ayouni K, Kharroubi G, Mallekh R, Hammami W, Marouani R, Mhamdi M, Ben Salah A, Triki H, Bettaieb J. Seroprevalence of hepatitis A virus infection in Central-West of Tunisia. J Med Virol 2021;93:3666-71. [PMID: 32986240 DOI: 10.1002/jmv.26563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Jacobsen KH. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb Perspect Med. 2018;8. [PMID: 29500305 DOI: 10.1101/cshperspect.a031716] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
5 Andani A, van Elten TM, Bunge EM, Marano C, Salgado F, Jacobsen KH. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Rev Vaccines 2020;19:795-805. [PMID: 32955965 DOI: 10.1080/14760584.2020.1813575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ayouni K, Naffeti B, Ben Aribi W, Bettaieb J, Hammami W, Ben Salah A, Ammar H, Ben Miled S, Triki H. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact. BMC Infect Dis 2020;20:627. [PMID: 32842988 DOI: 10.1186/s12879-020-05318-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kareem N, Al-Salahat K, Bakri FG, Rayyan Y, Mahafzah A, Sallam M. Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital. Pathogens 2021;10:1081. [PMID: 34578114 DOI: 10.3390/pathogens10091081] [Reference Citation Analysis]
8 Lankarani KB, Honarvar B, Molavi Vardanjani H, Kharmandar A, Gouya MM, Zahraei SM, Baneshi MR, Ali-Akbarpour M, Kazemi M, Seif M, Fard SAZ, Emami A. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. Vaccine 2020;38:7100-7. [PMID: 32917416 DOI: 10.1016/j.vaccine.2020.08.071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Badur S, Öztürk S, Ozakay A, Khalaf M, Saha D, Van Damme P. A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region. Hum Vaccin Immunother 2021;17:3710-28. [PMID: 34213403 DOI: 10.1080/21645515.2021.1920871] [Reference Citation Analysis]
10 Honarvar B, Zahedroozegar MH, Asmarian N, Zahedroozegar A, Saber K, B Lankarani K. Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran. Hepat Mon 2022;21. [DOI: 10.5812/hepatmon-122238] [Reference Citation Analysis]
11 Badur S, Öztürk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O, Hanif K, Saha D. Hepatitis A in the Eastern Mediterranean Region: a comprehensive review. Hum Vaccin Immunother 2022;:2073146. [PMID: 35617508 DOI: 10.1080/21645515.2022.2073146] [Reference Citation Analysis]
12 Ouardani I, Turki S, Aouni M, Romalde JL. Detection and Molecular Characterization of Hepatitis A Virus from Tunisian Wastewater Treatment Plants with Different Secondary Treatments. Appl Environ Microbiol 2016;82:3834-45. [PMID: 27107113 DOI: 10.1128/AEM.00619-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Herzog C, Van Herck K, Van Damme P. Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence. Hum Vaccin Immunother 2021;17:1496-519. [PMID: 33325760 DOI: 10.1080/21645515.2020.1819742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health 2017;10:513-7. [PMID: 28162965 DOI: 10.1016/j.jiph.2016.09.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
15 Akbulut UE, Arslan E. Hepatitis A Seroprevalence in Mogadishu, Somalia. J Trop Pediatr 2022;68:fmac009. [PMID: 35134249 DOI: 10.1093/tropej/fmac009] [Reference Citation Analysis]
16 Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach. BMC Infect Dis 2018;18:119. [PMID: 29514609 DOI: 10.1186/s12879-018-3034-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
17 López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D, Sanchez-Alemán MÁ, Romero-Martínez M, DeAntonio R, Cervantes-Apolinar MY, Cortes-Alcalá R, Alpuche-Aranda C. Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis. Vaccine 2018;36:8094-9. [PMID: 30337174 DOI: 10.1016/j.vaccine.2018.10.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]